Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01544738|
Recruitment Status : Completed
First Posted : March 6, 2012
Last Update Posted : March 6, 2012
Movement slowness (bradykinesia) is one of the main motor symptoms in Parkinson Disease (PD). Several studies have shown that patients with PD exhibit slowness because they are unable to modulate, in an optimal way, the velocity of voluntary motor acts not induced by external stimulation. Indeed, these patients have difficulties to integrate multi-sensorial information, mainly proprioception.
The investigators investigated changes in shoulder velocity during pointing movements by patients with PD after stimulation of soft tissues (aponeurosis) of upper limb muscles. The stimulation consisted of manipulating, with a hook (the diacutaneous fibrolysis method), the aponeurotic tissues enrobing the heads of the upper limb muscles. This technique has previously been shown to decrease passive tension and the tendon reflex response of the manipulated muscle group. The investigators hypothesis is that aponeurotic manipulation of shoulder muscles therefore creates a modification in the proprioceptive information, which in return temporarily decreases the bradykinesia of shoulder movements.
|Condition or disease||Intervention/treatment||Phase|
|Parkinson Disease||Other: Aponeurotic stimulation (the diacutaneous fibrolysis method) Other: Placebo stimulation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||11 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Aponeurotic Stimulation Effect on Parkinson Bradykinesia|
|Study Start Date :||November 2008|
|Actual Primary Completion Date :||May 2009|
Experimental: Aponeurotic stimulation group
The stimulation consisted of manipulating, with a hook (the diacutaneous fibrolysis method), the aponeurotic tissues enrobing the heads of the trunk and upper limb muscles.
Other: Aponeurotic stimulation (the diacutaneous fibrolysis method)
Treatment consisted of manipulating, with a hook, the aponeurotic tissues enrobing the heads of the upper-limb muscles. The manipulation consisted of back and forth mobilization, applied perpendicularly to the axis of the muscular fibers. The mobilization is performed with both hands; the therapist's non-dominant hand performs a manual mobilization whereas the dominant hand follows the movement with the hook. The hook allows the therapist to be very precise about the location of the tissues that are stretched. This stretch is realized at the level of the aponeurotic fibers presenting the greatest resistance to perpendicular movement. The shape of the hook is chosen to avoid discomfort or pain during manipulation. To spread the pressure exerted by the spatula on a very local point, it is important to fill completely the curved part of the hook with the adjacent soft tissues. We manipulated muscle from the proximal insertion towards the distal, giving special attention to the tendons.
Active Comparator: Placebo stimulation group
Placebo stimulation (PS) consisted of manipulating the skin along the same paths over the trunk, shoulder and arm muscles that were the targets for treatment in the Aponeurotic stimulation group.
Other: Placebo stimulation
Placebo stimulation (PS) consisted of manipulating the skin along the same paths over the trunk, shoulder and arm muscles that were the targets for treatment in the AS group
- 3D kinematic movement parameters and upper limb muscles electromyographic activation [ Time Frame: Participants will be followed for the duration of the clinical test (2 weeks) ]
- Unified Parkinson's Disease Rating Scale (UPDRS) [ Time Frame: Participants will be followed for the duration of the clinical test (2 weeks) ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01544738
|ULB-FSM Laboratory of neurophysiology and movement biomechanics|
|Brussels, Belgium, 1070|
|Principal Investigator:||Ana Bengoetxea, PhD||Université Libre de Bruxelles|
|Study Chair:||Françoise Leurs, PhD Student||Université Libre de Bruxelles|
|Study Chair:||Leslie Rigal, Master Student||Université Libre de Bruxelles|
|Study Director:||Guy Cheron, PhD||Université Libre de Bruxelles|